Research Insight
Research Insight
McKesson Specialty Health – Qualified Clinical Data Registry
McKesson Specialty Health has received approval from the Centers for Medicare and Medicaid Services (CMS) to participate in the Merit-Based Incentive Payment System (MIPS) 2018 program year as a Qualified Clinical Data Registry (QCDR). This is the second consecutive...
Research Insight
Advanced immunolabeling reagents and tools from vector laboratories now from bio-techne
Bio-Techne now offers reagents and kits from Vector Laboratories, a leader in advanced labeling and detection solutions. Their innovative proprietary immunolabeling kits offer reliable, sensitive, and low background detection.
In October 2017, Bio-Techne started distributing Vector Laboratories' flagship products to...
Research Insight
MEDITECH Announces Collaboration with Arcadia Healthcare Solutions
MEDITECH, a leading Enterprise Health Record (EHR) vendor, is pleased to announce a collaboration with Arcadia Healthcare Solutions to integrate aggregated data into MEDITECH's Web EHR and Analytics solution for improved Population Health Management.
This collaboration is a major step...
Research Insight
Inova Diagnostics Receives FDA Clearance for the First Fully Automated, Random Access Calprotectin Test
Inova Diagnostics, a world leader in autoimmune disease diagnostic systems and reagents for the clinical laboratory, is proud to announce the clearance of QUANTA Flash® Calprotectin by the US FDA.
QUANTA Flash Calprotectin aids in the diagnosis of inflammatory bowel...
Research Insight
Duke-Led Team Develops More Accurate Tool to Track New HIV Infections
Researchers at the Duke Human Vaccine Institute have led an effort to develop a more accurate way to gauge the incidence of HIV infections in large populations, which will improve research and prevention strategies worldwide.
The new method more correctly...
Research Insight
Cancer Immunotherapy May Work Better in Patients with Specific Genes
Cancer cells arise when DNA is mutated, and these cells should be recognized as “foreign” by the immune system. However, cancer cells have found ways to evade detection by the immune system.
New drugs called immune checkpoint inhibitors can restore...
Research Insight
Lenox Hill Hospital enrolls first patient in the nation in new trial investigating optimal treatment for complex coronary heart disease
Lenox Hill Hospital’s heart team is the first in the U.S. to successfully enroll a patient into the HYBRID Trial, a major national, multi-center clinical trial to determine whether a nonsurgical procedure alone, or a combination of surgery and...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read